CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
301117 Jiayuan Science and Technology
- 24.30
- +1.55+6.81%
Market Closed Apr 30 15:00 CST
2.24BMarket Cap174.82P/E (TTM)
24.65High22.72Low98.46KlotVolume22.72Open22.75Pre Close236.36MTurnover17.35%Turnover Ratio195.97P/E (Static)92.26MShares40.5652wk High1.72P/B1.38BFloat Cap21.7052wk Low27.30Limit Up56.75MShs Float99.25Historical High18.20Limit Down8.48%Amplitude20.72Historical Low--Dividend TTM24.01Avg Price38.96KlotAsk--Div YieldTTM100Lot Size53.04KlotBid
Jiayuan Science and Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -28.98%36.08M | -23.25%213.74M | -30.63%109.46M | -36.58%87.19M | 17.27%50.81M | 33.30%278.47M | 34.33%157.79M | 56.55%137.48M | -24.16%43.33M | -3.11%208.91M |
| Refunds of taxes and levies | ---- | ---- | 27.60%2.37M | -92.20%145.14K | ---- | ---- | 3,725.96%1.86M | 3,725.96%1.86M | -80.24%2.49K | --1.23M |
| Cash received relating to other operating activities | 42.43%3.09M | -39.11%5.84M | -34.50%6.79M | -26.95%4.83M | 16.86%2.17M | 128.05%9.59M | 67.11%10.36M | 27.22%6.62M | 13.00%1.85M | -13.88%4.21M |
| Cash inflows from operating activities | -26.06%39.17M | -23.77%219.58M | -30.23%118.62M | -36.85%92.17M | 17.25%52.98M | 34.39%288.06M | 37.42%170.01M | 56.83%145.96M | -23.14%45.18M | -2.80%214.34M |
| Goods services cash paid | 56.09%85.75M | -33.38%152.79M | 0.20%119.84M | -7.96%84.41M | 22.26%54.93M | -18.97%229.35M | -39.31%119.6M | -46.57%91.71M | -30.38%44.93M | 41.32%283.03M |
| Staff behalf paid | -2.47%21.05M | 21.19%74.44M | 32.23%56.11M | 41.34%39M | 42.47%21.59M | 56.78%61.42M | 46.37%42.43M | 40.23%27.59M | 30.92%15.15M | 48.16%39.18M |
| All taxes paid | 374.81%7.44M | -47.11%3.63M | -42.94%4.21M | -25.64%2.09M | 1,191.89%1.57M | -78.55%6.86M | -78.01%7.37M | -85.21%2.82M | -99.40%121.37K | 46.11%31.98M |
| Cash paid relating to other operating activities | -10.98%6.45M | -7.78%39.55M | 1.08%32.73M | 7.53%17.9M | -31.76%7.25M | -16.90%42.89M | -9.40%32.39M | -18.65%16.65M | -21.93%10.62M | 133.56%51.61M |
| Cash outflows from operating activities | 41.44%120.69M | -20.59%270.41M | 5.50%212.89M | 3.34%143.4M | 20.49%85.33M | -16.09%340.52M | -31.67%201.79M | -39.88%138.77M | -35.62%70.82M | 49.91%405.81M |
| Net cash flows from operating activities | -151.95%-81.52M | 3.10%-50.83M | -196.58%-94.27M | -812.06%-51.23M | -26.20%-32.36M | 72.60%-52.46M | 81.48%-31.78M | 105.22%7.19M | 49.94%-25.64M | -281.44%-191.46M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --130M | 3.20%1.29B | ---- | ---- | ---- | -47.26%1.25B | ---- | ---- | ---- | --2.37B |
| Cash received from returns on investments | -70.65%689.36K | -15.37%6.81M | -0.12%6.17M | -4.09%4.65M | -41.16%2.35M | -48.82%8.05M | -47.36%6.17M | -35.06%4.85M | 79.50%3.99M | --15.73M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -18.24%3.1K | ---- | ---- | ---- | --3.79K | --580 | --580 | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | 10.53%1.05B | -6.67%700M | -28.00%360M | ---- | -48.92%950M | -44.03%750M | --500M | ---- |
| Cash inflows from investing activities | -63.93%130.69M | 3.08%1.3B | 10.46%1.06B | -6.65%704.65M | -28.10%362.35M | -47.27%1.26B | -48.91%956.17M | -43.98%754.85M | 22,562.14%503.99M | --2.39B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -43.65%16.4M | 180.44%127.13M | 149.97%52.71M | 150.61%46.01M | 253.81%29.1M | 30.11%45.33M | -13.03%21.09M | 4,600.43%18.36M | 3,734.86%8.22M | 1,071.22%34.84M |
| Cash paid to acquire investments | --130M | 3.20%1.29B | ---- | ---- | ---- | -47.26%1.25B | --1M | --1M | ---- | --2.37B |
| Net cash paid to acquire subsidiaries and other business units | ---- | -98.60%848.48K | --848.48K | ---- | ---- | --60.74M | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | 10.53%1.05B | -6.67%700M | -28.00%360M | ---- | -48.92%950M | -44.03%750M | --500M | ---- |
| Cash outflows from investing activities | -62.38%146.4M | 4.56%1.42B | 13.52%1.1B | -3.04%746.01M | -23.44%389.1M | -43.61%1.36B | -48.41%972.09M | -42.60%769.36M | 236,869.87%508.22M | 80,745.77%2.4B |
| Net cash flows from investing activities | 41.28%-15.71M | -23.61%-121.16M | -197.82%-47.39M | -185.07%-41.35M | -532.01%-26.75M | -413.01%-98.01M | -27.12%-15.91M | -304.95%-14.51M | -310.63%-4.23M | -542.29%-19.11M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --198K | --792K | --792K | ---- | ---- | ---- | ---- | ---- | ---- | --1.01B |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --198K | --792K | --792K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | --160M | --100M | --100M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | --1M | ---- | ---- | --22K | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 800.00%198K | --161.79M | --100.79M | --100M | --22K | ---- | ---- | ---- | ---- | 1,189.42%1.01B |
| Borrowing repayment | ---- | --100M | --100M | --1M | --1M | ---- | ---- | ---- | ---- | 126.74%79.36M |
| Dividend interest payment | 8,669.96%268.46K | -75.34%3.41M | -75.43%3.4M | -76.61%3.11M | --3.06K | -63.73%13.85M | -63.71%13.84M | -65.02%13.31M | ---- | 2,069.85%38.18M |
| Cash payments relating to other financing activities | -41.47%1.54M | -21.77%4.97M | 18.72%6.47M | 4.23%4.53M | 252.44%2.63M | -69.58%6.36M | -72.44%5.45M | -78.07%4.35M | -95.92%745.23K | 188.34%20.89M |
| Cash outflows from financing activities | -50.25%1.81M | 436.40%108.39M | 469.56%109.87M | -51.03%8.65M | 387.03%3.63M | -85.40%20.21M | -85.86%19.29M | -86.66%17.66M | -97.78%745.23K | 214.59%138.44M |
| Net cash flows from financing activities | 55.43%-1.61M | 364.29%53.4M | 52.93%-9.08M | 617.44%91.35M | -384.08%-3.61M | -102.32%-20.21M | -102.21%-19.29M | -102.01%-17.66M | -100.08%-745.23K | 2,435.96%872.72M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | -86.42%16.62K | --24.26K | --24.26K | --19.88K | --122.39K | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -57.65%-98.84M | 30.48%-118.57M | -124.99%-150.71M | 95.17%-1.21M | -104.77%-62.69M | -125.76%-170.56M | -109.74%-66.99M | -103.35%-24.97M | -103.30%-30.62M | 3,630.29%662.15M |
| Add:Begin period cash and cash equivalents | -21.50%434.97M | -23.55%553.54M | -23.55%553.54M | -23.55%553.54M | -23.48%554.08M | 1,068.94%724.09M | 1,068.94%724.09M | 1,068.94%724.09M | 1,068.94%724.09M | -23.24%61.94M |
| End period cash equivalent | -31.59%336.13M | -21.42%434.97M | -38.70%402.83M | -21.00%552.33M | -29.14%491.38M | -23.55%553.54M | -12.38%657.11M | -13.42%699.13M | -29.97%693.48M | 1,068.94%724.09M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.